RNA, variant U1 small nuclear 33 (RNVU1-33)

RNA, variant U1 small nuclear 33 (RNVU1-33; also called U1A5 or RNU1-87P) is one of many U1 snRNA pseudogenes or sequence variants dispersed throughout the human genome[2]. The canonical U1 snRNA is an essential component of the spliceosome, binding to the 5′ splice site of pre-mRNAs to initiate splicing. However, RNVU1-33 represents a non-protein-coding, non-canonical sequence that resembles U1 snRNA but contains mutations, insertions, or deletions that typically prevent it from forming a fully functional U1 snRNP complex[2]. Although some U1 snRNA pseudogenes are transcribed and may participate in gene regulation (e.g., as non-coding RNAs, competitive miRNA decoys, or precursors for small RNAs in limited contexts), there is no evidence that RNVU1-33 functions as a therapeutic target, has direct disease associations, or significantly impacts splicing regulation beyond potential minor non-coding RNA roles[2][3]. Most pseudogene-derived snRNAs, including this variant, have undefined biological activity and are not considered validated molecular targets or receptors. Key Point: While canonical U1 snRNA is essential for spliceosome function and pre-mRNA splicing, RNVU1-33 is a poorly characterized, likely non-functional pseudogene or non-coding variant, not a conventional druggable target, receptor, or enzyme[2][3].

Other names

U1A5RNU1-87PRNA, U1 small nuclear 87, pseudogeneRNVU1-33

Not applicable (For drugs; no known mechanism for this variant as a target)